MENU
SMMT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Summit Therapeutics (SMMT) Ownership - Who owns Summit Therapeutics?

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
601 Brickell Key Drive
Phone
+1 305 203-2034
Employees
265
Web
https://www.smmttx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
10.87B
P/E Ratio
26.36
Total Cash
598.73M
Projected Growth
N/A
Total Debt
20.04M
Revenue
N/A
Risk (Beta)
1.32
Dividend Yield
N/A
Total Cash/Share
0.77
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
SMMT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of novel medicines

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
601 Brickell Key Drive
Phone
+1 305 203-2034
Employees
265
Web
https://www.smmttx.com